Skip to main content
Log in

Cardiac sarcoidosis after glucocorticoid therapy evaluated by 18F-fluorodeoxyglucose PET/MRI

  • Images that Teach
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, et al. Feasibility of FDG-PET in myocarditis: Comparison to CR using integrated PET/MRI. J Nucl Cardiol. 2016. doi:10.1007/s12350016-0616-y.

    Google Scholar 

  2. Wada K, Niitsuma T, Yamaki T, Masuda A, Ito H, Kubo H, et al. Simultaneous cardiac imaging to detect inflammation and scar tissue with 18F-fluorodeoxyglucose in cardiac sarcoidosis. J Nucl Cardiol. 2016;23:1180–2.

    Article  PubMed  Google Scholar 

  3. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;17:1683–90.

    Article  Google Scholar 

Download references

Disclosure

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takatoyo Kiko MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kiko, T., Masuda, A., Nemoto, A. et al. Cardiac sarcoidosis after glucocorticoid therapy evaluated by 18F-fluorodeoxyglucose PET/MRI. J. Nucl. Cardiol. 25, 685–687 (2018). https://doi.org/10.1007/s12350-017-1066-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-017-1066-x

Keywords

Navigation